.Nature Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint calls for introduction of individuals with MASLD and dimension of liver results in cardio-- renal-- metabolic tests, when records advise mechanistically plausible benefits and medical security-- as well as details factors to consider for test concept and regulative approval.